Dare to Move: Treatment of Movement Phobia in Patient With Low Back Pain
NCT ID: NCT01158339
Last Updated: 2021-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2010-01-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our hypothesis is that Cognitive Behavioural Therapy (CBT) with physical intervention during group sessions focusing on fear and avoidance behaviour will be more effective than physical therapy alone.
The study has two arms. Both will receive education related to LBP and appropriate advice regarding how to react and behave towards their LBP.
The main focus in the intervention group will be:
* Identifying their fear of movements and perform the frightened movements during the group sessions.
* Reassuring that gradually normalizing daily activities will not be harmful but rather reduce their pain.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exposure-based Treatment for Avoidant Back Pain Patients
NCT01484418
Information or Physical Activity for Chronic LBP
NCT00410319
Exposure Therapy and Safety-seeking Behavior in Chronic Low Back Pain
NCT01971151
EFFects of EXPosure and Cognitive-behavioural Therapy for Chronic BACK Pain
NCT05294081
The Effect of Exercise on Motion Perception and Fear in Low Back Pain
NCT05433311
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The fear and avoidance model developed by Vlaeyen and Linton has been recommended to be applied in the treatment of patients with chronic low back pain. No randomized controlled study has been published comparing the use of a fear and avoidance treatment with a comparison treatment. Such a study is highly warranted to examine if the model actually has a superior effect compared to other CBT-based treatments. In addition, it is of vital importance to examine whether all patients profit better from such a treatment or whether it only will demonstrate superior effect in a subgroup of patients with chronic low back pain.
PROBLEMS OF INTEREST:
Main aims are to improve the treatment of patients with chronic LBP by:
* 1\) Testing the effect of a treatment assumed by the international scientific community to be the treatment of choice;
* 2\) To develop a diagnostic screening procedure that at an initial examination can differentiate patients that need special treatment attention in the form of exposure towards feared movements from those who can benefit sufficiently from just receiving appropriate advice.
* 3\) To identify the mechanism of change in the treatment of LBP.
METHODS:
Subjects will be recruited from general practitioners in the county of Nord-Trøndelag and from our department.
The study is clinical prospective and randomized. Each session will be videotaped. Two independent raters will rate three random sessions from both the intervention and non-intervention groups. Treatment differentiability will be measured by assessing the amount of time (minutes) spent exposing the patients to various movements in the session (ISE). According to the manuals, amount of ISE in CBGT (cognitive Behavioural Group Therapy) should be zero and between ten to twenty minutes in the CBGT-ISE (cognitive Behavioural Group Therapy- In Session Exposure) condition.
In addition, in both groups the therapists conducting the treatments are instructed to measure amount of time devoted to ISE in each session.
The therapist will rate every session. Three out of six sessions will also be timed and rated by two independent raters. The consistency of the time measured by the therapist and the independent raters will be compared in order to assure correctness of reported time spent in session. The raters will also asses the quality of the sessions. If the ratings are consistent across therapists and independent raters, a total ISE score for each treatment group will be computed.
THE TWO ARMS:
Arm 1: CBGT Patients will be given a manualised group treatment based on a fear and avoidance model. A main focus will be identifying fear of movements. The patients will in a spoken manner be reassured that they gradually can begin to perform normal daily activities and perform movements in a normal manner without using various forms of safety behaviours. Dysfunctional thinking patterns will be identified and challenged. Ten to twenty minutes of each session will be devoted to reassuring patients that various forms of feared movements can be performed in a graded fashion based on a feared hierarchy.
Arm 2: CBGT-ISE Patients will be given a manualised group treatment based on a fear and avoidance model. A main focus will be identifying fear of movements. The patients will in a spoken manner be reassured that they gradually can begin to perform normal daily activities and perform movements in a normal manner without using various forms of safety behaviours. Dysfunctional thinking patterns will be identified and challenged.
Ten to twenty minutes of each session will be devoted to actually exposing the patients to various feared movements and performing these in a graded fashion based on a fear hierarchy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1: CBGT
Cognitive Behavioural Group Therapy (CBGT)
Arm 1: CBGT
Intervention according to previously mentioned methods.
Arm 2: CBGT-ISE
Cognitive Behavioural Group Therapy, with in-Session Exposure (CBGT-ISE).
Arm 2: CBGT-ISE
Intervention with active performance of the feared movements during group sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Arm 2: CBGT-ISE
Intervention with active performance of the feared movements during group sessions.
Arm 1: CBGT
Intervention according to previously mentioned methods.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pain of such a severity that life of quality is reduced.
* The patient's main problem must be LBP, localized from L1 to S1.
* The pain must not be caused by nerve root affection (e.g. herniated disc)
* The patient has to be able to understand instructions given in Norwegian and to take part in a group activity.
* The patient must be partly or fully on sick leave from work.
* The patient must have a regular work to return to.
Exclusion Criteria
* LBP that clearly is secondary to other somatic or psychiatric disorders.
* Alcohol and drug abuse.
* LBP caused by ankylosing spondylitis and other spondylarthropathies.
* Patients with "red flags" such as bladder- and anal paresis, impotence or progressing paresis.
* Ongoing insurance affairs for all types of sickness, injuries and accidents both against insurance companies and NAV (The Norwegian Labour and Welfare Administration)
* Indication for back surgery or performed back surgery last 12 months
* On medication known to cause depression or other psychiatric symptoms
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helse Nord-Trøndelag HF
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tore Charles Stiles, prof
Role: STUDY_DIRECTOR
Norwegian University of Science and Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Levanger Hospital
Levanger, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ryum T, Hartmann H, Borchgrevink P, de Ridder K, Stiles TC. The effect of in-session exposure in Fear-Avoidance treatment of chronic low back pain: A randomized controlled trial. Eur J Pain. 2021 Jan;25(1):171-188. doi: 10.1002/ejp.1659. Epub 2020 Oct 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REK No 2010/48-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.